Coherus BioSciences
Coherus BioSciences, based in Redwood City, CA, is dedicated to advancing next-generation cancer therapeutics through a diverse portfolio of immuno-oncology therapies. Their innovative approach focuses on combination therapies aimed at improving patient outcomes for those with challenging tumor types.
The company's pipeline includes promising candidates such as toripalimab-tpzi, the only FDA-approved treatment for recurrent or metastatic nasopharyngeal carcinoma, among other investigational drugs designed to target the tumor microenvironment. Coherus is committed to conducting clinical trials that evaluate the safety and effectiveness of these therapeutics, emphasizing their mission to transform cancer treatment and extend survival for patients.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.